| | 83480-29-9 Basic information More.. |
| Product Name: | Voglibose | | Synonyms: | Voglistat;epi-Inositol, 2,3-dideoxy-2-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-4-C-(hydroxymethyl)-;2,3-Dideoxy-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-4-C-(hydroxymethyl)-epi-inositol;Beigrace;Jumeal;Voglibose ,98%;3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol;N-(1,3-Dihydroxyprop-2-yl)valiolamine | | CAS: | 83480-29-9 | | MF: | C10H21NO7 | | MW: | 267.28 | | EINECS: | 1312995-182-4 | | Mol File: | 83480-29-9.mol |  |
Use
Voglibose was introduced in Japan for the treatment of postprandial
hyperglycemia in diabetic patients. As an orally active α-D-glucosidase inhibitor, it
is effective in decreasing the release of glucose from carbohydrate ingestion and
slowing the increase of postprandial blood glucose levels, as demonstrated in
animals and humans following sucrose and starch loading. In addlion, voglibose
was reported to have prophylactic effect in genetically obese Wistar rats,
maintaining low plasma levels of glucose, triglyceride and insulin, indicating a
potential usefulness for the management of other carbohydrate-dependent
metabolic disorders such as obesity. Voglibose is much more potent and has fewer
side effects than acarbose, another agent in its class.
- Voglibose
-
- US $0.00 / g
- 2025-04-25
- CAS:83480-29-9
- Min. Order: 1g
- Purity: 99%min
- Supply Ability: 1000 G
- Voglibose
-
- US $0.00-0.00 / mg
- 2025-04-25
- CAS:83480-29-9
- Min. Order: 10mg
- Purity: 95%+
- Supply Ability: 100000
- Voglibose
-
- US $1.00 / kg
- 2025-04-23
- CAS:83480-29-9
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10 mt
|
|
83480-29-9
Recommend Suppliers |
|